StudySignal is a digital-first clinical trial patient recruitment platform — delivering precision targeting, IRB-compliant campaigns, validated referrals, and real-time analytics for sponsors who can't afford to fall behind on enrollment.
Enrollment delays are among the most costly and disruptive challenges in clinical drug development. Physician referrals, site-based outreach, and print advertising are no longer sufficient in a world where patients are digitally native, actively researching their conditions, and spending hours each day on the same platforms your campaigns could be reaching them on.
StudySignal closes that gap — bringing the full power of modern digital marketing to patient recruitment, with the regulatory rigor, therapeutic area depth, and end-to-end workflow management that sponsors require.
Precision targeting and advanced pre-screening reduce per-patient acquisition costs compared to traditional recruitment methods.
Condition-specific behavioral and demographic targeting identifies ideal candidates faster and at scale — across any indication.
Simultaneous deployment across Google, Meta, Reddit, and emerging platforms puts your study in front of patients wherever they are most active.
Patient psychology-informed creative and optimized landing experiences convert interest into qualified referrals.
Real-time analytics and transparent reporting give sponsors full visibility into spend, performance, and ROI at every stage.
Advanced pre-screening and validated referral delivery ensures sites receive only qualified, protocol-aligned candidates.
StudySignal manages the complete patient acquisition journey — from initial digital targeting through validated referral delivery to your clinical sites. Our integrated platform eliminates the gaps and handoff failures that define point-solution approaches.
Explore the Full PlatformCustom-built, study-specific recruitment website serving as the central conversion engine for each program.
Real-time dashboards, automated site distribution, and comprehensive reporting for all stakeholders.
Simultaneous, condition-specific campaigns across Google, Meta, Reddit, TikTok, and specialized patient communities.
Therapeutic area-informed creative developed with regulatory compliance and patient psychology built in from the start.
Patient Acquisition Cost tracking, channel attribution, conversion optimization, and ROI reporting in real time.
Multi-stage pre-qualification ensures only protocol-aligned candidates reach your sites.
Every patient who reaches your sites has already completed our multi-stage qualification process. Here's what the journey looks like.
Patient encounters a condition-targeted digital ad across Google, Meta, Reddit, or another active platform.
Patient clicks through to the study-specific recruitment website and learns about the trial.
Patient completes a progressive pre-screening questionnaire designed around protocol eligibility criteria.
Eligible patients select their preferred site from a searchable, geography-matched database.
Patient submits contact referral form. Data is routed instantly to the appropriate site coordinator.
Patient is contacted by a secondary screener or site representative for final qualification confirmation.
StudySignal's digital recruitment platform is study-type and indication-agnostic. We build condition-specific campaigns from the ground up for each study — tailoring messaging, targeting, and patient journey design to the unique profile of every patient population we're asked to reach.
Many sponsors assemble separate vendors for digital advertising, website development, pre-screening, and reporting. The result: data silos, handoff failures, inconsistent quality, and no single partner accountable for enrollment outcomes.